CN

TAI HENG OFFICIAL NOTICE

source: author: Publication time:2021-12-03 browse:1229

Notice

In order to meet our rapid development needs, our new R&D center in Minhang District, Shanghai will be operational in January, 2022. Our current FDA inspected GMP facility (FEI 3006986091) in Longwu Road, Shanghai remains operational for all existing API products, including but not limit to production, packaging, testing and other related production activities. Therefore, the new site will not change the relative company information previously registered in USFDA in any way, nor will it affect the production and operation of our API products.


ADMINISTRATION DEPARTMENT

of TAI HENG INDUSTRY CO., LTD

执行时间:0.048918962478638秒 查询数据库10次 内存使用:1.288 mb - 386.578 kb = 932.219 kb 当前模式:developer